Metabolomic profiling can identify biologically active metabolites that may serve as biomarkers and provide mechanistic insights into primary dilated cardiomyopathy.
May support metabolomic biomarker discovery in primary DCM; hypothesis-generating and should not yet change practice.
Metabolomic profiling identifies biologically active metabolites that could serve as markers of primary DCM and impart protective or harmful effects on cardiac structure and function.
No takes yet. Share an insight, caveat, or question.
Alexander et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: